Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Keiji Miyajima is active.

Publication


Featured researches published by Keiji Miyajima.


Gastroenterologia Japonica | 1988

Experimental immunological intrahepatic cholestasis model

Mizoguchi Y; Yoshihide Sakagami; Keiji Miyajima; Sukeo Yamamoto; Seiji Morisawa

SummaryHeat-killedPropionibacterium acnes (P. acnes) was intravenously injected into tuberculin-sensitized guinea pigs, and 7 days later, purified protein derivative (PPD) was also injected intravenously resulting in marked reductions in bile flow and bile acid excretion. Serum levels of bile acids and cholesterol were increased, and the activities of alkaline phosphatase (ALK-p) and leucine aminopeptidase (LAP) were also elevated. Histological examination revealed dilatation of bile canaliculi and diminution of microvilli. These results indicated that intrahepatic cholestasis was induced. These pathological changes were not detected in guinea pigs in which PPD was not injected. In this experimental model, the tuberculin-sensitized lymphocytes were infiltrated into the liver byP. acnes injection and the cholestatic factor was produced by PPD injection, resulting in the induction of intrahepatic cholestasis.


Gastroenterologia Japonica | 1987

Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis

Yasuhiro Mizoguchi; Keiji Miyajima; Yoshihide Sakagami; Kenzo Kobayashi; Takashi Arai; Isamu Fukamachi; Sukeo Yamamoto; Seiji Morisawa

SummaryA novel lymphokine, which we have designated as cholestatic factor (CF), was produced from peripheral blood lymphocytes of patients with drug-induced allergic intrahepatic cholestasis by stimulation with a causative drug in the presence of the liver soluble fraction containing liver-specific lipoprotein (LSP). Marked reductions in bile flow and bile acid excretion were induced in rats by injecting CF through a mesenteric vein. In order to confirm the presence of CF in the liver tissue of patients, we attempted to detect this lymphokine by using the enzyme-labelled antibody method. As a result, CF was found in the liver tissue of eleven out of thirty-eight patients with acute intrahepatic cholestasis including one with hepatitis A type, one with hepatitis B type, two with hepatitis non-A non-B type, five with drug-induced allergic hepatitis, one with alcoholic hepatitis and one with lupoid hepatitis. In contrast, CF was undetectable in the liver tissue of patients without intrahepatic cholestasis. These results may additionally support our assumption that CF plays an important role in the induction of intrahepatic cholestasis in various liver diseases.


Kanzo | 1987

The protective effect of prostaglandin E1 on experimentally-induced acute hepatic failure.

Yasuhiro Mizoguchi; Hiroko Tsutsui; Hiroshi Kuboi; Jae-Dam Lee; Yumiko Fujinobu; Chie Kodama; Keiji Miyajima; Yoshihide Sakagami; Shuichi Seki; Tetsuo Arakawa; Kenzo Kobayashi; Sukeo Yamamoto; Seiji Morisawa

Propionibacterium acnes (P.acnes)加熱死菌をマウスに静注し,7日後に少量のグラム陰性菌由来のlipopolysaccharide (LPS)を静注すると,ほとんどのマウスは広範な肝壊死を起こして死亡する.しかし,このような実験的肝障害を誘導する際に,prostaglandin (PG)E1を投与すると,マウスの生存率は高くなり,肝の組織学的変化も著明に改善される.このPGE1の肝障害抑制機構を明らかにするため,著者らは肝障害を誘導する肝粘着性細胞の活性化に及ぼすPG E1の影響を検討するとともに粘着性細胞由来の肝細胞障害因子に対するPG E1の肝細胞防御作用をしらべた.その結果,PG E1は肝粘着性細胞の活性化を抑制して細胞障害因子の遊離を抑制するぼかりでなく,肝細胞に直接作用して肝細胞を障害因子の作用から防御することが明らかとなった.


Kanzo | 1986

Studies on the action mechanism of cholestatic factor : The effect of colchicine on intrahepatic cholestasis induced by cholestatic factor.

Yoshihide Sakagami; Toukan Shin; Yasuhiro Mizoguchi; Keiji Miyajima; Yoshikazu Shindo; Toshihiro Higashimori; Shuichi Seki; Hiroshi Takeda; Hiroko Tsutsui; Kenzo Kobayashi; Seiji Morisawa; Sukeo Yamamoto

急性肝内胆汁うっ滞を誘導するリンホカイン,催胆汁うっ滞因子(cholestatic factor, CF)の胆汁形成抑制の機序をしらべるために,胆汁形成を調節するとされる肝細胞内細胞骨格のmicrotubules (Mt)-microfilaments (Mf)系に及ぼすCFの影響について検討した.コルヒチン(Mt inhibitor)を単独でラットに静注しても総胆管からの胆汁排泄は抑制されなかった.しかし,コルヒチンとCF (Mf inhibitor)の両者投与群では,CF単独投与の時にみられる胆汁流量の減少よりさらに高度の胆汁排泄の抑制を認めた.すなわち,コルヒチンとCFは,相加的ではなく相乗的に胆汁排泄を抑制することが示された.以上の結果は,胆汁形成にはMt とMfの協調作用が必要であり,胆汁分泌機構において“microtubular microfilamentous system”が存在するという仮説を支持するとともに,CFが“microtubular microfilamentous system”を障害して肝内胆汁うっ滞を誘導する可能性が示唆された.


Kanzo | 1986

A prolonged case of drug-induced allergic hepatitis exhibiting the production of antibody to liver cell membrane.

Yasuhiro Mizoguchi; Tokan Shin; Keiji Miyajima; Hiroko Katoh; Hiroko Tsutsui; Tohru Kanno; Shunichi Seki; Teisuke Kamata; Sukeo Yamamoto; Shigeru Tanino; Takeyuki Monna; Seiji Morisawa

バモ酸ヒドロキシジンおよび肝水解物製剤(プロヘパール)によると推測される薬物アレルギー性肝炎の症例を観察中,血清中に抗肝細胞膜抗体が出現したことが,antibodydependent cell-mediated cytotoxicity (ADCC)テストによって認められた.この症例は,起因薬物の投与を中止した後も肝障害が続き,臨床経過が遷延した.また,肝機能障害は抗肝細胞膜抗体の出現と平行したので,本症例の肝細胞障害には肝細胞膜に対する抗体が密接に関与していると推測された.


Kanzo | 1985

Studies on the effect of estrogen on the antibody response in lupoid hepatitis.

Yasuhiro Mizoguchi; Hiroko Katoh; Hiroko Tsutsui; Keiji Miyajima; Yoshihide Sakagami; Toshihiro Higashimori; Shunichi Seki; Sukeo Yamamoto; Yoshihiro Ikemoto; Arai T; Seiji Morisawa

健常ヒトおよびルポイド肝炎患者の末梢血から単核細胞を分離してpokeweed mitogen(PWM)で刺激すると,trinitrophenyl化したヒツジ赤血球(TNP-SRBC)に対する抗体産生が誘導されたが,抗体産生細胞の誘導には両者の間に有意差を認めなかった.健常ヒトの末梢血単核細胞をPWMで刺激する際に,同時にエストロゲン(E)を添加すると,1×10-8~1×10-6mg/mlの添加によって抗体産生が増強され,5×10-7mg/mlの添加でその増強は最大であった.これに反して,ルポイド肝炎患者の場合は比較的高濃度のE(1×10-5mg/ml)の添加で抗体産生が最高に増強され,健常ヒトの場合とEに対する応答に差異が認められた.この差異がどの細胞populationの応答能の変化によるか検討すると,リンパ球と単球の両者の応答の低下が認められた.以上の結果から,ルポイド肝炎においてはEに対する反応性が健常ヒトと異なることが示唆された.


Kanzo | 1984

The effect of Kupffer cells on mitogen-induced lymphocyte transformation.

Arai T; Yasuhiro Mizoguchi; Keiji Miyajima; Yoshihiro Ikemoto; Hiroko Tsutsui; Hiroko Kato; Sukeo Yamamoto; Seiji Morisawa

ヒト末梢血から分離した単核細胞をin vitroでphytohemagglutinin, concanavalin Aまたはpokeweed mitogenで刺激し,3H-thymidineの酸不溶性分画へのとりこみを指標としてリンパ球幼若化反応を検討した.この実験系に,ラット肝から分離したKupffer細胞の48時間培養上清をmitogenと同時に添加すると,3H-thymidineのとりこみは著明に抑制された.しかし,Kupffer細胞を培養する際にindomethacinを添加して48時間培養し,その培養上清をmitogenで単核細胞を刺激する際に加えると,リンパ球幼若化反応の抑制は有意に低下した.これらの結果から,Kupffer細胞培養上清中にはprostaglandinが存在し,これがmitogenによるリンパ球幼若化反応を抑制すると推測された.


Hepatology | 1987

The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model

Yasuhiro Mizoguchi; Hiroko Tsutsui; Keiji Miyajima; Yoshihide Sakagami; Shuichi Seki; Kenzo Kobayashi; Sukeo Yamamoto; Seiji Morisawa


Kanzo | 1986

Cholagogous effect of ursodeoxycholic acid in cholestatic factor-induced intrahepatic cholestasis.

Keiji Miyajima; Yasuhiro Mizoguchi; Yoshihide Sakagami; Kenzo Kobayashi; Sukeo Yamamoto; Seiji Morisawa


Osaka city medical journal | 1989

Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.

Mizoguchi Y; Keiji Miyajima; Kioka K; Seki S; Kenzo Kobayashi; Seiji Morisawa

Collaboration


Dive into the Keiji Miyajima's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge